Neuraxis (NRXS) Inventory (2022 - 2025)
Neuraxis (NRXS) posted Inventory of $257132.0 for Q4 2025, up 133.21% sequentially from $110256.0 in Q3 2025, and up 480.07% YoY from $44328.0 in Q4 2024.
Neuraxis (NRXS) Inventory (2022 - 2025) Analysis & Trends
Neuraxis has reported Inventory for 4 years, with the latest figure at $257132.0 in Q4 2025.
- Quarterly Inventory rose 480.07% year-over-year to $257132.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $257132.0 (up 480.07% YoY) and the FY2025 annual result came in at $257132.0, up 480.07% from the prior year.
- Inventory improved to $257132.0 in Q4 2025 per NRXS's latest filing, from $110256.0 in the prior quarter.
- Over five years, Inventory peaked at $257132.0 in Q4 2025 and troughed at $20194.0 in Q1 2024.
- A 4-year average of $67834.9 and a median of $43457.5 in 2023 frame the typical range for Inventory.
- The sharpest annual moves came in 2023 and 2025: Inventory plunged 55.91% in 2023, then jumped 480.07% in 2025.
- Over 4 years, Inventory stood at $48133.0 in 2022, then tumbled by 55.91% to $21220.0 in 2023, then soared by 108.9% to $44328.0 in 2024, then surged by 480.07% to $257132.0 in 2025.
- According to Business Quant data, Inventory over the past three periods registered $257132.0, $110256.0, and $131432.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Neuraxis | 74.54 Mn | 66.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 257,132.00 |
| Sep 30, 2025 | 110,256.00 |
| Jun 30, 2025 | 131,432.00 |
| Mar 31, 2025 | 37,421.00 |
| Dec 31, 2024 | 44,328.00 |
| Sep 30, 2024 | 22,458.00 |
| Jun 30, 2024 | 42,710.00 |
| Mar 31, 2024 | 20,194.00 |
| Dec 31, 2023 | 21,220.00 |
| Sep 30, 2023 | 34,530.00 |
| Jun 30, 2023 | 44,205.00 |
| Dec 31, 2022 | 48,133.00 |